Supporting Cancer Research
|
Events
|
Resource Library
|
Contact Us
Our Company
Our Products and
Services
Our Partners
For Investors
For Media
Careers
Corporate Social
Responsibility
For Investors
Investor Home
Why Invest?
Investor Presentation
Investor Kit
Financials
Quarterly Results
Annual Report
Archived Annual Reports
Financial Summary
SEDAR
EDGAR
Investor Kit
Report Request Form
Stock Info
Stock Quote
Historical Price Lookup
Investment Calculator
Dividend Information
Analyst Coverage
Events
2012
2011
2010
Industry Events
News Releases
2012
2011
2010
2009
2008
2007
Corporate Governance
Corporate Governance
Annual Report
Proxy Circular
Directors and Management
Board of Directors
Executive Management Team
Compensation of Directors
Board and Committee Charters
Guidelines & Practices
Disclosure Required by Section 303A.11 of NYSE
Global Business Practice Standards
FAQ
Contact IR
E-mail Alerts
Report Request Form
Home
|
News Releases 2006
10-10-2006
MDS Nordion Recognized for Environmental Excellence
09-26-2006
First Clinical Trial Launched by MDS Nordion to Study Innovative Cancer Treatment
04-19-2006
MDS Nordion Signs Agreement with Bradmer Pharmaceuticals Inc.for Novel Brain Cancer Therapeutic
03-22-2006
MDS Nordion Offers Advanced Cancer Therapy Systems in Europe
02-26-2006
MDS Nordion Provides Long-term Cobalt Supply for Sterilization Industry
02-22-2006
MDS Announces New Agreement on MAPLE Reactor Project
02-16-2006
MDS Nordion to Supply Cardiac Imaging Pharmaceutical for Molecular Insight Pharmaceuticals, Inc.
01-30-2006
MDS Nordion Appoints Christopher Wagner as Senior Vice-President of Sales and Marketing
